Informations générales (source: ClinicalTrials.gov)
Usefulness of Protoarray®Microarray for Identifying Biomarkers in Idiopathic Juvenile Arthritis Antinuclear Antibodies Positive.
Interventional
N/A
University Hospital, Montpellier (Voir sur ClinicalTrials)
juin 2015
décembre 2016
29 juin 2024
Juvenile idiopathic arthritis (JIA) is the most common form of arthritis in children. The
etiology is unknown. Several types of arthritis fall under the JIA heading.
Oligoarticular JIA with antinuclear antibodies affects about half of all children. There
's no specific markers. Our purpose is to identify new markers in this pathology. The
ProtoArray®Human Protein Microarray allows rapid and efficient detection of protein
interaction using a suitable protein or small molecule probe. The investigators hope so
detect novel potential autoantigen biomarkers specific in JIA.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Cardiology paediatric consultation, Arnaud de Villeneuve Hospital - 34295 - Montpellier - France | Aurelia CARBASSE, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria for experimental group :
- child age from 2 to 16 years
- Oligoarticular JIA with antinuclear antibodies
- with or without uveitis
Exclusion criteria for experimental group :
- immunosuppressive and biological therapy
Inclusion Criteria for control group :
- child age from 2 to 16 years
- child age from 2 to 16 years
- Oligoarticular JIA with antinuclear antibodies
- with or without uveitis
Exclusion criteria for experimental group :
- immunosuppressive and biological therapy
Inclusion Criteria for control group :
- child age from 2 to 16 years